Houston, United States
Keikku, developed by Lapsi Health, is pioneering the medical technology landscape with its distinction as the world’s first FDA-cleared smart stethoscope integrated with an AI medical scribe. Heralded by the World Record Academy, Keikku revolutionizes healthcare by enabling clinicians to simultaneously listen, document, and diagnose, enhancing both efficiency and patient care.
Introduced to the market in 2024, Keikku builds a significant bridge to modern medicine by melding clinical-grade auscultation abilities with sophisticated AI-driven documentation. The product empowers healthcare professionals to capture crucial insights swiftly and at the point of care, streamlining workflow while maintaining focus on patient interactions.
While information about its headquarters or past investments is not readily available, Keikku's promising technology and innovative approach present a compelling investment opportunity for venture capitalists looking to spearhead technological advancement within the healthcare industry.
